38
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Effect of diquafosol three per cent ophthalmic solution on tear film and corneal aberrations after cataract surgery

, MD, , MD, , MD, , MD PhD, , MD PhD & , MD PhD
Pages 590-594 | Received 08 Aug 2016, Accepted 01 Dec 2016, Published online: 15 Apr 2021
 

Abstract

Background

The aim was to evaluate the effect of diquafosol on tear film parameters and corneal aberrations after cataract surgery.

Methods

This retrospective, comparative, observational case series included patients who underwent cataract surgery with or without peri‐operative use of diquafosol three per cent ophthalmic solution. Patients in group I (31 eyes) were treated with diquafosol three per cent ophthalmic solution six times a day from one week before surgery to three months after surgery. Patients in group II (33 eyes) underwent cataract surgery without being administered diquafosol. Tear film break‐up time (BUT), the ocular surface disease index (OSDI), the Oxford Scheme score, Schirmer's test I and corneal aberrations were determined before and at one and three months post‐surgery.

Results

In group I, the BUT, OSDI and Oxford Scheme score showed significant improvement at one and three months post‐surgery (p = 0.002 for BUT at one month and three months, p = 0.023 and p = 0.049 for OSDI at one month and three months and p = 0.001 and p = 0.026 for Oxford Scheme at one month and three months), compared to baseline. In group II, the BUT, OSDI and Oxford Scheme score did not show any significant improvement during the follow‐up period. In both groups, Schirmer's test I significantly decreased at three months post‐surgery (p = 0.011 for group I and p = 0.034 for group II), compared to baseline. There were significant differences in the BUT and OSDI between the groups at three months post‐surgery (p = 0.037 for and p = 0.011 for ). Regarding the corneal aberration, there were no significant differences between the groups at three months post‐surgery.

Conclusion

Peri‐operative application of diquafosol three per cent ophthalmic solution may prevent dry eye‐related ocular surface changes accompanied by improvement of ocular symptom. No definite changes in corneal aberrations were noted.

ACKNOWLEDGEMENT

This work was supported by a grant of the Korean Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea (HI14C2044).

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Purchase Issue

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 84.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.